A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

BMS747158

Single dose administration.

Trial Locations (1)

90095

UCLA Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY